Sfoglia per Autore
The clinical role of PIK3CA mutations in colorectal cancer
2008 Pratesi N, Simi L, Sestini R, Nobili S, Vignoli M, Landini I, Cianchi F, Valanzano R, Genuardi M, Mini E, Orlando C
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles
2008 Landini I; Napoli C; Nobili S; Morganti M; Rigacci L; Bosi A; Mini E
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer
2009 Mini E; Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Mazzei T.
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results
2010 Napoli C; Nobili S; Landini I; Perrone G; Puccini B; Antognoli G; Doria M; Martelli M; Finolezzi E; Rigacci L; Di Lollo S; Bosi A; Mini E
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies.
2010 Nobili S; Mini E; Landini I; Gabbiani C; Casini A; Messori L.
Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study.
2010 Magherini F; Modesti A; Bini L; Puglia M; Landini I; Nobili S; Mini E; Cinellu MA; Gabbiani C; Messori L.
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma
2011 Napoli C; Nobili S; Landini I; Perrone G; Valenti A; Brugia M; Puccini B; Antognoli G; Doria M; Martelli M; Finolezzi E; Rigacci L; Di Lollo S; Bosi A; Mini E
Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand.
2011 Maiore L; Cinellu MA; Michelucci E; Moneti G; Nobili S; Landini I; Mini E; Guerri A; Gabbiani C; Messori L.
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer
2011 Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Cortesini C; Mazzei T; Mini E
Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(II) compounds with sulfur and phosphorus donors.
2011 Mügge C; Rothenburger C; Beyer A; Görls H; Gabbiani C; Casini A; Michelucci E; Landini I; Nobili S; Mini E; Messori L; Weigand W.
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies
2011 Crea F; Nobili S; Paolicchi E; Perrone G; Napoli C; Landini I; Danesi R; Mini E
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression
2012 Nobili S; Landini I; Mazzei T; Mini E
Proteomic Analysis of Ovarian Cancer Cell Responses to Cytotoxic Gold Compounds
2012 F.Guidi; I.Landini;M. Puglia;F.Magherini;C.Gabbiani;M.A.Cinellu;S.Nobili;T.Fiaschi;L.Bini;E.Mini;L.Messori;A.Modesti
Synthesis, Structural Characterization, Solution Behavior, and in Vitro Antiproliferative Properties of a Series of Gold Complexes with 2-(2'-Pyridyl)benzimidazole as Ligand: Comparisons of Gold(III) versus Gold(I) and Mononuclear versus Binuclear Derivatives
2012 Serratrice M; Cinellu MA; Maiore L; Pilo M; Zucca A; Gabbiani C; Guerri A; Landini I; Nobili S; Mini E; Messori L.
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: Solution behavior, reactions with model proteins, antiproliferative properties
2012 Maiore L; Cinellu MA; Nobili S; Landini I; Mini E; Gabbiani C; Messori L
The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics
2013 Guidi F; Modesti A; Landini I; Nobili S; Mini E; Bini L; Puglia M; Casini A; Dyson PJ; Gabbiani C; Messori L
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents
2014 Messori L; Marchetti L; Massai L; Scaletti F; Guerri A; Landini I; Nobili S; Perrone G; Mini E; Leoni P; Pasquali M; Gabbiani C.
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c.)
2014 Gamberi T; Massai L; Magherini F; Landini I; Fiaschi T; Scaletti F; Gabbiani C; Bianchi L; Bini L; Nobili S; Perrone G; Mini E; Messori L; Modesti A
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma
2014 Nobili S; Napoli C; Puccini B; Landini I; Perrone G; Brugia M; Benelli G; Doria M; Martelli M; Finolezzi E; Di Rocco A; Del Fava E; Rigacci L; Di Lollo S; Bosi A; Mini E.
Druggable Targets in Pancreatic Adenocarcinoma
2014 Nobili S; Tassi R; Landini I; Perrone G; Napoli C; Mini E
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile